Ivo Chamrád

Dr. Ivo Chamrád

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2014 in The Plant Journal
Verified
Journal Article
Closed access
PDF file
RKRoman Kouril
Roman Kouril
OSOndřej Strouhal
Ondřej Strouhal
LNLukáš Nosek
Lukáš Nosek
RLRené Lenobel
René Lenobel
ICIvo Chamrád
Ivo Chamrád
PIPetr Ilík
Petr Ilík

15 September 2009 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
VKVladimir Krystof
Vladimir Krystof
ICIvo Chamrád
Ivo Chamrád
RJRadek Jorda
Radek Jorda
JKJiří Kohoutek
Jiří Kohoutek

22 July 2014 in Cytogenetic and Genome Research
Verified
Journal Article
Closed access
PDF file
BPBeáta Petrovská
Beáta Petrovská
HJHana Jeřábková
Hana Jeřábková
ICIvo Chamrád
Ivo Chamrád
JVJan Vrána
Jan Vrána
RLRené Lenobel
René Lenobel
Jaroslav DolezelJaroslav Dolezel
Jaroslav Dolezel
Many proteins are present in the nucleus; some are involved with its structural and functional organization, some with gene expression, and some with cell division. The plant nuclear proteome has not been well explored. Its characterization requires extraction methods which minimize both the artifactual alteration of the proteins and the extent of contamination with non-nuclear proteins. The conventional multi-step fractionation procedure is both laborious and prone to contamination. Here, we describe a single-step method based on flow sorting. The method allows the separation of G1, S and G2 phase nuclei and minimizes the risk of contamination by non-nuclear proteins. Preliminary results obtained using G1 phase cell nuclei from barley root tips indicate that flow sorting coupled with a protein/peptide separation and mass spectrometry will permit a comprehensive characterization of the plant nuclear proteome.

14 September 2023 in Journal of Experimental Botany
Verified
Journal Article
Open access
PDF file
APAndrej Pavlovič
Andrej Pavlovič
JKJana Koller
Jana Koller
OVOndřej Vrobel
Ondřej Vrobel
ICIvo Chamrád
Ivo Chamrád
RLRené Lenobel
René Lenobel
Petr TarkowskiPetr Tarkowski
Petr Tarkowski
The carnivorous plants in the order Caryophyllales co-opted jasmonate signalling from plant defence to botanical carnivory. However, carnivorous plants have at least 11 independent origins, and here we ask whether jasmonate signalling has been co-opted repeatedly in different evolutionary lineages. We experimentally wounded and fed the carnivorous plants Sarracenia purpurea (order Ericales), Cephalotus follicularis (order Oxalidales), Drosophyllum lusitanicum (order Caryophyllales), and measured electrical signals, phytohormone tissue level, and digestive enzymes activity. Coronatine was added exogenously to confirm the role of jasmonates in the induction of digestive process. Immunodetection of aspartic protease and proteomic analysis of digestive fluid was also performed. We found that prey capture induced accumulation of endogenous jasmonates only in D. lusitanicum, in accordance with increased enzyme activity after insect prey or coronatine application. In C. follicularis, the enzyme activity was constitutive while in S. purpurea was regulated by multiple factors. Several classes of digestive enzymes were identified in the digestive fluid of D. lusitanicum. Although carnivorous plants from different evolutionary lineages use the same digestive enzymes, the mechanism of their regulation differs. All investigated genera use jasmonates for their ancient role, defence, but jasmonate signalling has been co-opted for botanical carnivory only in some of them.

8 December 2009 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
JWJózefa Węsierska-Gądek
Józefa Węsierska-Gądek
ICIvo Chamrád
Ivo Chamrád
VKVladimir Krystof
Vladimir Krystof
Progression of the cell cycle is controlled by various activating and inhibiting cellular factors. The subtle balance between these counteracting regulators in normal cells ensures proper cell cycle progression and facilitates cellular responses to a variety of stress stimuli. Key activators include cyclin-dependent kinases (CDKs) and, consequently, loss or inactivation of CDK inhibitors contributes to the escape of cancer cells from cell cycle control and hyperactivation of CDKs occurs in various neurodegenerative disorders. However, these adverse effects may be compensated by pharmacological counterparts. Inhibitors of CDKs representing various classes of compounds with diverse CDK inhibitory patterns have been developed, but inhibitors that have high selectivity and offer highly targeted activity against both cell cycle and transcriptional CDKs are of particular interest. This review focuses on pharmacological CDK inhibitors that have entered clinical trials and some compounds that have been evaluated preclinically. Recent discoveries in cell cycle regulation have provided rationales for clinical applications of CDK inhibitors in both monotherapeutic and combined therapeutic regimens.

20 August 2013 in Journal of Proteome Research
Verified
Journal Article
Closed access
ICIvo Chamrád
Ivo Chamrád
URUwe Rix
Uwe Rix
ASAlexey Stukalov
Alexey Stukalov
MGManuela Gridling
Manuela Gridling
KPKatja Parapatics
Katja Parapatics
KBKeiryn L. Bennett
Keiryn L. Bennett